Vanguard Personalized Indexing Management LLC Purchases 2,518 Shares of CME Group Inc. $CME

Vanguard Personalized Indexing Management LLC grew its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 5.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 48,273 shares of the financial services provider’s stock after acquiring an additional 2,518 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in CME Group were worth $13,182,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Asset Dedication LLC lifted its holdings in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares during the period. FNY Investment Advisers LLC bought a new position in shares of CME Group during the 4th quarter valued at $27,000. Hilton Head Capital Partners LLC bought a new position in shares of CME Group during the 4th quarter valued at $28,000. Global Wealth Strategies & Associates lifted its holdings in shares of CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock valued at $30,000 after buying an additional 100 shares during the period. Finally, Legacy Wealth Managment LLC ID lifted its holdings in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

Insiders Place Their Bets

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 44,044 shares of company stock worth $13,297,507. Corporate insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CME shares. Morgan Stanley lowered their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a report on Thursday, April 23rd. Argus reissued a “hold” rating on shares of CME Group in a report on Wednesday, March 4th. Jefferies Financial Group reduced their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Barclays reduced their price objective on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research note on Thursday, April 23rd. Finally, Keefe, Bruyette & Woods initiated coverage on CME Group in a research note on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price objective for the company. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $305.71.

View Our Latest Research Report on CME

CME Group Stock Performance

NASDAQ:CME opened at $269.53 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $97.67 billion, a price-to-earnings ratio of 23.00, a price-to-earnings-growth ratio of 3.01 and a beta of 0.21. CME Group Inc. has a one year low of $244.56 and a one year high of $329.16. The business has a fifty day moving average price of $284.79 and a 200-day moving average price of $288.16.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the prior year, the business posted $2.80 EPS. CME Group’s revenue for the quarter was up 14.5% compared to the same quarter last year. Sell-side analysts forecast that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio is presently 44.37%.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.